Abstract:We have developed a genetic "intrakine" strategy to inactivate the CC-chemokine receptor 5 (CCR-5), the principal coreceptor for macrophage (M)-tropic HIV-1 viruses (Yang et al., 1997). The inactivation of CCR-5 was achieved by targeting a modified CC-chemokine (RANTES) to the lumen of the endoplasmic reticulum (ER) to block the transport of the newly synthesized CCR-5. The transduced lymphocytes with the phenotypic CCR-5 knockout were shown to be resistant to M-tropic HIV-1 infection. This study illustrated the feasibility of the intrakine strategy to block HIV-1 infection. In our current study, the potential clinical application of the intrakine approach was further evaluated in human peripheral blood lymphocytes (PBLs), PBLs were transduced with the RANTES intrakine gene by using retroviral vectors with the truncated low-affinity human nerve growth factor receptor (Delta NGFR) marker, and then isolated by an anti-NGFR antibody/magnetic bead method. The surface expression of CCR-5 in the transduced lymphocytes was dramatically inhibited, as demonstrated by flow cytometric assays. The transduced PBLs were shown to resist various types of M-tropic HIV-1 virus infection. The cell viability, cell proliferation rates, and cell surface markers of the intrakine-transduced PBLs were shown to be comparable to those of control PBLs. The transduced PBLs were also found to respond to the stimulation of various CXC- and CC-chemokines, other than RANTES. The transduced PBLs responded to tetanus antigen stimulation by increasing IL-2 production and cell proliferation. In addition, a functionally defective mutant of RANTES that retains its binding activity to CCR-5, but loses its signaling ability, was used to generate a mutant RANTES intrakine. The primary lymphocytes transduced with the mutant RANTES intrakine were found to be resistant to M-tropic HIV-1 infection. From these results, we conclude that the primary human lymphocytes transduced with either the wild-type or functionally defective RANTES intrakine are resistant to M-tropic HIV-1 infection, and maintain their basic biological functions. This study, therefore, indicates the potential clinical application of the intrakine approach for HIV-1 gene therapy.

Interaction of the CC-Chemokine RANTES with Glycosaminoglycans Activates a p44/p42 Mitogen-Activated Protein Kinase-Dependent Signaling Pathway and Enhances Human Immunodeficiency Virus Type 1 Infectivity

Chemokine Receptor Ccr5 Functionally Couples to Inhibitory G Proteins and Undergoes Desensitization

The Serum Levels and Roles of Regulated Upon Activation Normal T Cell Expressed and Secreted and Monocyte Chemoattractant Protein-1 in Human Immunodeficiency Virus-1 Infected Patients

Association of RANTES with the Replication of Severe Acute Respiratory Syndrome Coronavirus in THP-1 Cells.

Role of DC-SIGN Induced Signaling Pathway in the Activation of HIV-1 Virus

Gp120 Binding with DC-SIGN Induces Reactivation of HIV-1 Provirus Via the NF-κB Signaling Pathway

Regulation of Human Immunodeficiency Virus Type 1 Infection, Β-Chemokine Production, and CCR5 Expression in CD40L-Stimulated Macrophages: Immune Control of Viral Entry

N-terminal Proteolytic Processing by Cathepsin G Converts RANTES/CCL5 and Related Analogs into a Truncated 4-68 Variant

Porcine reproductive and respiratory syndrome virus (PRRSV) infection activates chemokine RANTES in MARC-145 cells.

HIV-1 Downregulates the Expression and Phosphorylation of Receptor Tyrosine Kinase by Targeting the NF-κB Pathway

Human Immunodeficiency Virus (HIV)-1 Tat Downregulates the Phosphorylation of Recepteur D'origine Nantais (RON) Receptor Tyrosine Kinase Induced by Macrophage-Stimulating Protein

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

Multiple Pathways of Amino Terminal Processing Produce Two Truncated Variants of RANTES/CCL5.

HIV-1 Glycoprotein 41 Ectodomain Induces Activation of the CD74 Protein-Mediated Extracellular Signal-Regulated Kinase/mitogen-Activated Protein Kinase Pathway to Enhance Viral Infection.

Anti-HIV type 1 activity of wild-type and functional defective RANTES intrakine in primary human lymphocytes.

Mechanism Underlying Increased Expression of a Member of the Serine/ Threonine Kinase Family (citron Kinase) Induced by HIV-1 Infection

Structural and Functional Studies of the Potent Anti-Hiv Chemokine Variant P2-Rantes

The effect of RANTES chemokine genetic variants on early HIV-1 plasma RNA among African American injection drug users.

Interferon Regulatory Factor 1 is an Essential and Direct Transcriptional Activator for Interferon Γ-Induced RANTES/CCl5 Expression in Macrophages

Increased cAMP-PKA signaling pathway activation is involved in up-regulation of CTLA-4 expression in CD4+ T cells in acute SIVmac239-infected Chinese rhesus macaques

Regulation of CC Chemokine Receptor 5 and CD4 Expression and Human Immunodeficiency Virus Type 1 Replication in Human Macrophages and Microglia by T Helper Type 2 Cytokines.